Phase II study of androgen synthesis inhibition with ketoconazole, hydrocortisone, and dutasteride in asymptomatic castration-resistant prostate cancer (Q35011129)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of androgen synthesis inhibition with ketoconazole, hydrocortisone, and dutasteride in asymptomatic castration-resistant prostate cancer |
scientific article |
Statements
1 reference
Phase II study of androgen synthesis inhibition with ketoconazole, hydrocortisone, and dutasteride in asymptomatic castration-resistant prostate cancer (English)
1 reference
Philip W Kantoff
1 reference
Mary-Ellen Taplin
1 reference
Tomasz M Beer
1 reference
Meredith M Regan
1 reference
Yoo-Joung Ko
1 reference
Glenn J Bubley
1 reference
Stephen E Duggan
1 reference
Lillian Werner
1 reference
Christopher W Ryan
1 reference
Paul Mathew
1 reference
Shi-Ming Tu
1 reference
Samuel R Denmeade
1 reference
William K Oh
1 reference
Oliver Sartor
1 reference
Christos S Mantzoros
1 reference
Roger Rittmaster
1 reference
Steven P Balk
1 reference
3 November 2009
1 reference
1 reference
15
1 reference
22
1 reference
7099-7105
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference